Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $915.40 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $377.21 | 11 | $0 (2024) |
| Dynavax Technologies Corporation | $217.79 | 2 | $0 (2022) |
| Lilly USA, LLC | $90.91 | 5 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $77.52 | 3 | $0 (2022) |
| Amarin Pharma Inc. | $53.47 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $24.38 | 1 | $0 (2022) |
| PFIZER INC. | $24.31 | 1 | $0 (2022) |
| Quidel Corporation | $20.00 | 1 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $15.71 | 1 | $0 (2022) |
| ABBVIE INC. | $14.10 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.83 | 3 | Novo Nordisk Inc ($118.92) |
| 2023 | $15.85 | 1 | Novo Nordisk Inc ($15.85) |
| 2022 | $527.96 | 18 | Dynavax Technologies Corporation ($217.79) |
| 2021 | $216.76 | 7 | Novo Nordisk Inc ($181.61) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $118.92 | General |
| 07/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 02/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: PRIMARY CARE | ||||||
| 09/29/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Diabetes | ||||||
| 09/22/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $101.29 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/15/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: PRIMARY CARE | ||||||
| 08/18/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Cardiovascular | ||||||
| 07/21/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Cardiovascular | ||||||
| 06/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Diabetes | ||||||
| 06/13/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $116.50 | General |
| Category: Hepatitis B Vaccine | ||||||
| 06/09/2022 | ABBVIE INC. | LINZESS (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/12/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Respiratory | ||||||
| 04/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: PRIMARY CARE | ||||||
| 04/14/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Diabetes | ||||||
| 04/07/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiovascular | ||||||
| 03/31/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Diabetes | ||||||
| 03/03/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/27/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Cardiovascular | ||||||
| 11/24/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: Diabetes | ||||||
| 10/08/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Diabetes | ||||||
| 09/10/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,562 | 1,833 | $245,435 | $85,524 |
| 2022 | 27 | 1,513 | 1,808 | $234,630 | $82,290 |
| 2021 | 25 | 1,307 | 1,423 | $192,570 | $72,107 |
| 2020 | 7 | 250 | 392 | $52,632 | $15,504 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 282 | 282 | $64,860 | $32,478 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 253 | $63,250 | $14,588 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 250 | 304 | $51,680 | $12,451 | 24.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $8,730 | $5,356 | 61.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 45 | 45 | $4,275 | $3,233 | 75.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $5,610 | $2,507 | 44.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $6,560 | $2,200 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $9,120 | $1,672 | 18.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 48 | 48 | $2,640 | $1,560 | 59.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 106 | 147 | $5,145 | $1,514 | 29.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 77 | 110 | $4,400 | $1,433 | 32.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 96 | 134 | $2,010 | $1,126 | 56.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,485 | $877.50 | 59.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 56 | 82 | $2,460 | $773.52 | 31.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 36 | $1,800 | $592.56 | 32.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 70 | 74 | $2,590 | $563.14 | 21.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 55 | 56 | $3,920 | $524.88 | 13.4% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 12 | 12 | $780.00 | $520.08 | 66.7% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 11 | $715.00 | $476.74 | 66.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 27 | 31 | $775.00 | $256.99 | 33.2% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 12 | 12 | $660.00 | $216.24 | 32.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 13 | 14 | $560.00 | $187.04 | 33.4% |
| 83550 | Iron binding capacity | Office | 2023 | 13 | 14 | $420.00 | $119.98 | 28.6% |
| 83540 | Iron level | Office | 2023 | 13 | 14 | $280.00 | $88.76 | 31.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 23 | 23 | $230.00 | $71.53 | 31.1% |
About Erin Yates
Erin Yates is a Registered Nurse healthcare provider based in Columbia, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2018. The National Provider Identifier (NPI) number assigned to this provider is 1205329257.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Erin Yates has received a total of $915.40 in payments from pharmaceutical and medical device companies, with $154.83 received in 2024. These payments were reported across 29 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($915.40).
As a Medicare-enrolled provider, Yates has provided services to 4,632 Medicare beneficiaries, totaling 5,456 services with total Medicare billing of $255,425. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner
- Location Columbia, MD
- Active Since 06/13/2018
- Last Updated 07/08/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1205329257
Products in Payments
- Heplisav-B (Drug) $217.79
- RYBELSUS (Drug) $146.71
- NURTEC ODT (Drug) $77.52
- Rybelsus (Drug) $59.06
- Vascepa (Drug) $53.47
- Ozempic (Drug) $52.52
- MOUNJARO (Drug) $41.50
- BREZTRI (Drug) $24.38
- ELIQUIS (Drug) $24.31
- Sofia (Device) $20.00
- TRULICITY (Drug) $18.13
- JARDIANCE (Drug) $16.13
- Livalo (Drug) $15.71
- EMGALITY (Drug) $15.15
- LINZESS (Drug) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Columbia
Amanda Goke, Aprn, Fnp-C, APRN, FNP-C
Registered Nurse — Payments: $17,238
Stephanie Whitbey, N.p, N.P
Registered Nurse — Payments: $9,510
Mrs. Andrea Oates, Msn, Fnp, MSN, FNP
Registered Nurse — Payments: $7,087
Jamie Markway, Fnp, FNP
Registered Nurse — Payments: $6,251
Tomeeka Hawthorne, Rn, RN
Registered Nurse — Payments: $6,028
Mrs. Cynthia Rose, Rn, RN
Registered Nurse — Payments: $4,516